Rheumnow Podcast

A focused conversation on the latest in psoriatic arthritis care - from emerging data and treatment strategies to real-world challenges in diagnosis and management. Hear expert perspectives, clinical pearls, and what's shaping PsA practice right now.

Stay plugged into the conversations, discoveries, and breakthroughs moving rheumatology forward. Real updates. Real context. For clinicians who never stop learning.

Dr. Jack Cush recaps ACR2025 with suggestions on how to best learn ACR25 content from RheumNow.com and our Videos and podcasts.

NEPTUNUS: Ianalumab in Sjogren's  Pulmonary hypertension in Sarcoidosis 

Restoring B Cell Compartments with CAR T: Molecular Data is Here   CAR-T: The Future

Revised Classification Criteria in axSpA https://www.youtube.com/watch?v=voFJrQo1ANU NSAID Addition Helps the Spine but not the Hips https://www.youtube.com/watch?v=wTKMC1MTwpE Biomarker Discovery in axSpA https://www.youtube.com/watch?v=X8Sc_3oBSVA Sexual Function in axSpA https://www.youtube.com/watch?v=r4_Nsh7e_oo Coping Strategies in axSpA https://www.youtube.com/watch?v=z9KdNuOu4nI "ROC-SpA Study" https://www.youtube.com/watch?v=kIEN39XRsSM Why do patients stay in clinical trials? https://www.youtube.com/watch?v=pVIBoN0jO2o What to do after first TNR failure in axSpA? https://www.youtube.com/watch?v=PVSyq_Y5-PE

ILD in Patients with Connective Tissue Disease  Fiber and Methotrexate  RA ILD Prediction: simple as a dipstick?  "Leftover Pain in Inflammatory Arthritis" 

From Pain to Wellness in PsA  Secukinumab vs Ustekinumab in PsA  Izokibep: still enthused about enthesitis?  Using Digital Apps to Modify Pain in axSpA

"ROC-SpA Study"  Secukinumab vs Ustekinumab in PsA  RA ILD Prediction: simple as a dipstick?  Sjogren's Disease: PROs as a Filter for Precision Medicine  Why do patients stay in clinical trials?  Using Digital Apps to Modify Pain in axSpA  IgG4: Rare but Treatable! 

From Pain to Wellness in PsA  IL-2 Therapy in SLE? Maybe  Sexual Function in axSpA  "Fact or Fiction: Trinetics Research at ACR"  CD1/BCMA Dual Targeting: One too many targets in SLE  Hydroxychloroquine Blood Levels  The Great Debate: AI in Rheumatology  Coping Strategies in axSpA  "What to do After First TNR Failure in axSpA"